News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shanghai Pharmaceutical Co., Ltd. Subsidiary Buys 51% of Jinhe Biotech



1/10/2012 11:01:01 AM

January 10, 2012 -- Shanghai Pharma announced its subsidiary, Shanghai Zhongxi Sunve Pharmaceutical, acquired a 51% stake in Shanghai Jinhe Biotechnology. Sunve produces APIs and intermediates for cancer drugs, and it has over half the China market for taxane APIs. Sunve is expected to report sales of 94 million RMB ($14.9 million) in 2011. The price was not disclosed. More details....

Stock Symbols: (SHA: 601607, HK: 2607)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES